3/26
08:19 am
lxeo
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $23.00 price target on the stock.
High
Report
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $23.00 price target on the stock.
3/25
11:14 am
lxeo
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its price target lowered by analysts at Royal Bank of Canada from $24.00 to $20.00. They now have an "outperform" rating on the stock.
High
Report
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its price target lowered by analysts at Royal Bank of Canada from $24.00 to $20.00. They now have an "outperform" rating on the stock.
3/25
08:17 am
lxeo
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $25.00 price target on the stock.
High
Report
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $25.00 price target on the stock.
3/24
12:14 pm
lxeo
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its price target lowered by analysts at Leerink Partners from $19.00 to $18.00. They now have an "outperform" rating on the stock.
High
Report
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its price target lowered by analysts at Leerink Partners from $19.00 to $18.00. They now have an "outperform" rating on the stock.
3/24
07:00 am
lxeo
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
High
Report
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
2/13
09:14 am
lxeo
NAVEGA THERAPEUTICS APPOINTS NEW STRATEGIC ADVISORS TO THE BOARD OF ADVISORS [Yahoo! Finance]
High
Report
NAVEGA THERAPEUTICS APPOINTS NEW STRATEGIC ADVISORS TO THE BOARD OF ADVISORS [Yahoo! Finance]
1/21
12:19 pm
lxeo
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $24.00 price target on the stock.
Low
Report
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $24.00 price target on the stock.
1/7
08:35 am
lxeo
Lexeo Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Medium
Report
Lexeo Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/7
07:30 am
lxeo
Lexeo Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Medium
Report
Lexeo Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference